Skip to main content
Premium Trial:

Request an Annual Quote

Benitec, Biomics Advance HBV Partnership

Premium

Benitec and its Chinese partner Biomics Biotechnologies have agreed to advance their collaboration to develop an expressed RNAi treatment for hepatitis B.

The companies began working together on the program in mid-2009, and finalized the arrangement a few months later (GSN 7/16/2009 & 9/9/2010). The first stage of the alliance identified target RNA sequences capable of blocking HBV replication, Benitec said.

Now, the partners aim to conduct proof-of-principle studies to optimize a preclinical drug candidate, a process expected to take around 18 months.

According to Benitec, the firms have agreed to share development costs, ownership of related intellectual property, and commercialization rights based on “an agreed division of territories.” Additional terms of the deal were not disclosed.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.